Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Scientific Reports
|
November 25, 2024
Bladder image stitching algorithm for navigation and referencing using a standard cystoscope
Ming Li, Nicole A Varble, Sandeep Gurram, et al.
The Journal of Urology
|
December 23, 2018
Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: Role of a Negative Confirmatory Magnetic Resonance Imaging-Ultrasound Fusion Biopsy
Jonathan B Bloom, Graham R Hale, Samuel A Gold, et al.
Turkish Journal of Urology
|
September 12, 2019
A multiparametric magnetic resonance imaging-based virtual reality surgical navigation tool for robotic-assisted radical prostatectomy
Sherif Mehralivand, Abhishek Kolagunda, Kai Hammerich, et al.
The Journal of Urology
|
June 1, 2018
Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer
Kareem N Rayn, Jonathan B Bloom, Samuel A Gold, et al.
Urologic Oncology
|
March 19, 2021
Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for intermediate risk prostate cancer patients
Jonathan B Bloom, Michael A Daneshvar, Amir H Lebastchi, et al.
Cancer Cell
|
September 13, 2011
The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels
Wing-Hang Tong, Carole Sourbier, Gennady Kovtunovych, et al.
BJU International
|
May 30, 2019
Use of multiparametric magnetic resonance imaging and fusion-guided biopsies to properly select and follow African-American men on active surveillance
Jonathan B Bloom, Amir H Lebastchi, Samuel A Gold, et al.
Urologic Oncology
|
August 8, 2025
Bacillus Calmette-Guérin (BCG) in combination with PANVAC™ vs. BCG alone in adults with high-grade BCG-refractory non-muscle-invasive bladder cancer
Matthew Ho, Alon Lazarovich, Ragheed Saoud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 15, 2022
Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy
Daniel M Girardi, Scot A Niglio, Amir Mortazavi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 11, 2020
Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors
Andrea B Apolo, Rosa Nadal, Daniel M Girardi, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Scientific Reports
|
November 25, 2024
Bladder image stitching algorithm for navigation and referencing using a standard cystoscope
Ming Li, Nicole A Varble, Sandeep Gurram, et al.
The Journal of Urology
|
December 23, 2018
Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: Role of a Negative Confirmatory Magnetic Resonance Imaging-Ultrasound Fusion Biopsy
Jonathan B Bloom, Graham R Hale, Samuel A Gold, et al.
Turkish Journal of Urology
|
September 12, 2019
A multiparametric magnetic resonance imaging-based virtual reality surgical navigation tool for robotic-assisted radical prostatectomy
Sherif Mehralivand, Abhishek Kolagunda, Kai Hammerich, et al.
The Journal of Urology
|
June 1, 2018
Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer
Kareem N Rayn, Jonathan B Bloom, Samuel A Gold, et al.
Urologic Oncology
|
March 19, 2021
Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for intermediate risk prostate cancer patients
Jonathan B Bloom, Michael A Daneshvar, Amir H Lebastchi, et al.
Cancer Cell
|
September 13, 2011
The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels
Wing-Hang Tong, Carole Sourbier, Gennady Kovtunovych, et al.
BJU International
|
May 30, 2019
Use of multiparametric magnetic resonance imaging and fusion-guided biopsies to properly select and follow African-American men on active surveillance
Jonathan B Bloom, Amir H Lebastchi, Samuel A Gold, et al.
Urologic Oncology
|
August 8, 2025
Bacillus Calmette-Guérin (BCG) in combination with PANVAC™ vs. BCG alone in adults with high-grade BCG-refractory non-muscle-invasive bladder cancer
Matthew Ho, Alon Lazarovich, Ragheed Saoud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 15, 2022
Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy
Daniel M Girardi, Scot A Niglio, Amir Mortazavi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 11, 2020
Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors
Andrea B Apolo, Rosa Nadal, Daniel M Girardi, et al.
Page
of 3